Ashok Bhandari
Corporate Officer/Principal bei PROTAGONIST THERAPEUTICS, INC.
Ursprung des Netzwerks ersten Grades von Ashok Bhandari
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 36 | |
| Public Company | Biotechnology | 32 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ashok Bhandari
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Chairman Sales & Marketing Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Treasurer General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Director/Board Member Human Resources Officer Director of Finance/CFO | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chief Executive Officer President | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Investor Relations Contact Director of Finance/CFO | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Founder | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Founder | |
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer General Counsel | |
| Stanford University | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| FIBROGEN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel General Counsel | |
| The University of Chicago | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Graduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Doctorate Degree | |
| University of Illinois | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
Presidio Partners
 Presidio Partners Investment ManagersFinance Presidio Partners is a venture capital firm founded in the year 1989 by Thomas R. Baruch. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| PDL BIOPHARMA, INC. | Biotechnology | Director/Board Member Chairman | |
| California Institute for Regenerative Medicine | General Government | Director/Board Member Director/Board Member Director/Board Member | |
| AUSPEX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Velocity Pharmaceutical Development LLC
 Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | Drugstore Chains | Director/Board Member Founder | |
| University of California | College/University | Corporate Officer/Principal Doctorate Degree | |
| Stanford University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| ARAVIVE, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Hinge Bio, Inc.
 Hinge Bio, Inc. BiotechnologyHealth Technology Hinge Bio, Inc. is a holding company, which engages in the development of specific and multi-specific antibodies. The company is headquartered in Burlingame, CA. | Biotechnology | Director/Board Member Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 49 |
| Australien | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 32 |
| Consumer Services | 13 |
| Commercial Services | 4 |
| Distribution Services | 2 |
| Finance | 2 |
Operativ
| Director/Board Member | 313 |
| Corporate Officer/Principal | 164 |
| Independent Dir/Board Member | 110 |
| Chief Tech/Sci/R&D Officer | 65 |
| Chairman | 63 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| John P. Walker | 39 |
| Nicholas G. Galakatos | 38 |
| Kathy LaPorte | 34 |
| Helen Kim | 33 |
| Elizabeth Czerepak | 31 |
| Ted Love | 31 |
| Arlene Morris | 28 |
| Samuel Saks | 28 |
| Harold Selick | 24 |
| Dan Spiegelman | 24 |
| R. Scott Greer | 23 |
| Lewis Williams | 23 |
| Keith Leonard | 20 |
| William Waddill | 19 |
| Paul Cleveland | 18 |
- Börse
- Insiders
- Ashok Bhandari
- Unternehmensverbindungen
